Julien Delaunay | Healthcare | Best Researcher Award

Dr. Julien Delaunay | Healthcare | Best Researcher Award

Dr. Julien Delaunay | Healthcare -Researcher in AI at Top Health Tech, Spain

Delaunay Julien is an accomplished researcher in the field of computer science, particularly known for his contributions to artificial intelligence (AI) and explainable machine learning models. His academic and professional journey spans multiple prestigious institutions across Europe and Canada. With a keen interest in making complex AI systems more interpretable, Julien has established himself as an expert in developing techniques that aim to enhance the transparency and trustworthiness of AI models, especially in natural language processing (NLP). His expertise is recognized globally through his publications, conference talks, and contributions to peer-reviewed journals. As an advocate for responsible AI, Julien actively engages in teaching, mentoring, and collaborative projects that bridge the gap between AI research and real-world applications. His passion for the field, combined with a commitment to advancing the next generation of AI researchers, makes him a leading figure in his area of study.

Profile:

Orcid

Education:


Julien’s academic background reflects his dedication to mastering and advancing the field of computer science. He completed his Ph.D. in Computer Science from Inria and Rennes 1 University in France (2020–2023), with guidance from renowned advisors in the field. His research during this time focused on AI explainability, particularly the development of novel counterfactual explanation techniques. Prior to his Ph.D., Julien completed both his Master’s in Computer Science at Rennes 1 University and Sherbrooke University in Canada, where he specialized in artificial intelligence, data mining, and parallel programming. His undergraduate education at Rennes 1 University further solidified his foundation in object-oriented programming and web technologies. Through this extensive educational journey, Julien has developed a robust understanding of both the theoretical and practical aspects of computer science, making him an expert in machine learning and its interpretability.

Experience:


Julien has accumulated a wealth of professional experience in both academic and research settings, with key roles at prestigious institutions across Europe. His most recent position is as a researcher in computer science at the Top Doctors Group in Barcelona, Spain (2024–Present), where he continues his work on AI explainability. Prior to this, he held various academic positions, including graduate teaching assistant at Rennes 1 University and Institut Agro in France, and visiting researcher at Aalborg University in Denmark (2022–2023). His professional career began with multiple internships at Inria in Rennes, where he explored the intersection of machine learning and AI transparency. In addition to his academic roles, Julien has been actively involved in mentoring students and has presented at various international conferences, further establishing his reputation as a leader in the field.

Research Interest:


Julien’s research focuses on the development and enhancement of AI explainability techniques, particularly for complex machine learning models in natural language processing. He is passionate about making AI systems more transparent and understandable to both experts and non-experts alike. His work includes the development of novel counterfactual explanation techniques and model-agnostic frameworks that allow users to understand the decision-making processes of AI models better. Julien’s interests extend beyond technical innovations; he is deeply engaged in studying the impact of these explanation techniques on users’ trust and comprehension of AI. This research is crucial for promoting ethical AI and ensuring that AI models can be deployed responsibly in real-world applications. His ongoing work explores the adaptation of explanation methods for different user roles, ensuring that AI systems cater to diverse needs in various domains.

Award:


Delaunay Julien’s work has been recognized globally through various awards and nominations, reflecting the significance and impact of his contributions to AI research. His innovative approaches to explainability and interpretability have positioned him as a leading researcher in his field. His research has not only advanced the academic understanding of AI transparency but also contributed to practical applications, making him a strong candidate for the Best Researcher Award. His ability to develop new frameworks and methods in machine learning, alongside his academic leadership and outreach efforts, makes him an exemplary figure deserving of recognition. Julien’s commitment to improving AI accessibility, as well as his dedication to educating and mentoring future generations of researchers, strengthens his eligibility for prestigious awards in the domain of computer science and AI.

Publication:


Julien has authored and co-authored several notable publications, many of which have been well-received by the AI and machine learning research community. His works are frequently cited, contributing to the growing body of literature on AI transparency and explainability. Here are some of his key publications:

  1. Delaunay J., Galárraga L., Largouët C. (2024). Does It Make Sense to Explain a Black Box With Another Black Box? Journal TAL: Explicabilité des modèles de TAL.
    • This paper compares and categorizes counterfactual explanation techniques for textual data, providing a deeper understanding of different counterfactual approaches.
      📘 Cited by: 25+ articles
  2. Delaunay J., Chaffin A. (2023). “Honey, Tell Me What’s Wrong”, Global Explainability of NLP Models through Cooperative Generation. Workshop on Analyzing and Interpreting Neural Networks for NLP at EMNLP 2023.
    • In this publication, Julien validated a novel global model-agnostic explanation technique for textual data.
      📘 Cited by: 15+ articles
  3. Delaunay J., Galárraga L., Largouët C., Van Berkel N. (2023). Adaptation of AI Explanations to Users’ Roles. Workshop on Human-Centered Explainable AI at CHI 2023.
    • This study explores how AI explanations can be adapted based on different user roles, contributing significantly to user-centered AI design.
      📘 Cited by: 10+ articles
  4. Wester J., Delaunay J., De Jong S., Van Berkel N. (2023). On Moral Manifestations in Large Language Models. Workshop on Moral Agent at CHI 2023.
    • The paper investigates the potential misinterpretation of large language models like ChatGPT as moral agents.
      📘 Cited by: 8+ articles
  5. Delaunay J., Galárraga L., Largouët C. (2022). When Should We Use Linear Explanations? International Conference on Information and Knowledge Management (CIKM).
    • This paper introduces the APE framework, which helps determine when linear explanations best approximate the decision boundaries of complex models.
      📘 Cited by: 12+ articles

Conclusion:


Delaunay Julien’s work exemplifies innovation, leadership, and dedication in the field of computer science, specifically in AI explainability. His research has not only advanced theoretical knowledge but also addressed practical challenges in the deployment of AI systems. Julien’s ability to develop novel techniques that enhance the transparency of complex machine learning models has positioned him as a leading figure in his field. His numerous publications, contributions to major conferences, and mentorship roles highlight his influence in shaping the future of AI. Despite opportunities for growth in terms of broader public engagement and application-driven research, Julien’s contributions make him a highly deserving nominee for the Best Researcher Award. His career trajectory shows immense promise, and he is set to continue influencing the AI research landscape for years to come.

Martin NICOL | Medical | Best Paper Award

Dr. Martin NICOL | Medical | Best Paper Award

Doctor at Cardiology department, Lariboisiere Saint Louis University of Paris, France

Dr. Martin Nicol is a distinguished French cardiologist with a specialization in cardio-oncology, cardiac imaging, and cardiovascular diseases. With over a decade of experience in both clinical and academic roles, he has made significant contributions to cardiology through his research, teaching, and clinical expertise. His work has garnered recognition at international conferences, and he continues to lead in the development of specialized cardiac care.

Profile:

SCOPUS

Education:

Dr. Nicol’s educational journey is rooted in some of France’s most prestigious institutions. He completed his medical degree from Université Paris 7 in 2018, where he also earned a Doctorate in Medicine. His postdoctoral training includes a DES in cardiology and vascular diseases from Université Paris 6. Dr. Nicol further specialized by obtaining several diplomas, including a DIU in cardio-oncology and echocardiography. His extensive academic background provided a solid foundation for his later research and clinical endeavors.

Experience:

Dr. Nicol’s professional experience spans across leading hospitals in Paris, where he served as an intern and later as a fellow in multimodal cardiac imaging at the Centre Cardiologique du Nord. He gained valuable experience in echocardiography, MRI, and cardiac scanning. From 2019 to 2021, he was the Chief of Clinic in the cardiology department at Lariboisière Hospital, where he developed specialized consultations in cardio-oncology. In 2022, he transitioned to private practice, joining the Maison Médicale de Mareil Marly and Ambroise Paré Hospital. Dr. Nicol also continues his work at Saint Louis Hospital, specializing in the treatment of amyloidosis.

Research Interest:

Dr. Nicol’s research is deeply centered on cardiovascular diseases, specifically focusing on cardiac amyloidosis, cardio-oncology, and cardiac imaging. His doctoral thesis on myocardial stiffness in heart failure highlighted his commitment to advancing diagnostic and treatment methods for complex cardiovascular conditions. He has collaborated with international research groups to further explore these areas, particularly in the integration of imaging modalities and their prognostic values.

Awards:

Dr. Nicol has received numerous accolades for his contributions to cardiology research. Notable among these is the Young Investigator Award at the Global Cardio-Oncology Summit in 2018 for his diagnostic score of cardiac involvement in AL amyloidosis. He also won several awards for his work on the cardiotoxicity induced by doxorubicin and trastuzumab, including the Best Oral Communication Award at GRRC 2018 and Best Poster Award at JFIC 2018.

Publications:

Dr. Nicol has published extensively in reputable cardiology journals. His work spans topics from subclinical left ventricular dysfunction during chemotherapy to the prognosis of cardiac amyloidosis. Some of his key publications include:

Nicol M, Deblaise J, Choussat R, Dubourg O, Mansencal N. “Side effects of ticagrelor: sinus node dysfunction with ventricular pause.” Int J Cardiol, 2015. Cited by 56 articles.

Nicol M, Baudet M, Cohen Solal A. “Subclinical left ventricular dysfunction during chemotherapy.” Card Fail Rev, 2019. Cited by 45 articles.

Nicol M, Cescau A, Baudet M, Harel S, Royer B. “Prognostic value of 123-I MIBG in AL amyloidosis.” Circ Cardiovasc Imaging, 2019. Cited by 38 articles.

Nicol M, Deney A, Lairez O, Vergaro G, Emdin M. “Prognostic value of cardiopulmonary exercise testing in cardiac amyloidosis.” Eur J Heart Fail, 2021. Cited by 29 articles.

Nicol M, Sadoune M, Azibani F. “Doxorubicin and trastuzumab induced cardiotoxicity in mice is not prevented by metoprolol.” ESC Heart Fail, 2021. Cited by 22 articles.

Nicol M, Siguret V, Vergaro G. “Thrombo-embolism and bleeding in patients with amyloidosis: A review.” ESC Heart Fail, 2022. Cited by 16 articles.

Nicol M, Hubert A, Coisne A. “Reproducibility of the 2016 American Society of Echocardiography-Algorithm for Estimation of Left Ventricular Filling Pattern.” Ultrasound Med Biol, 2022. Cited by 12 articles.

Nicol M, Vergaro G, Damy T. “Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis.” Front Cardiovasc Med, 2023. Cited by 10 articles.

Conclusion

Dr. Martin Nicol’s research contributions, particularly in the field of cardio-oncology and cardiac amyloidosis, make him a strong candidate for the Best Research Paper Award. His impressive record of publications, awards, and innovative research in multimodal cardiac imaging align well with the award’s criteria. Expanding his clinical trial work and focusing on mentorship could further enhance his qualifications, but his current profile already demonstrates a remarkable level of expertise and impact.

Shreyas Yakkali | Medicine and Dentistry | Best Researcher Award

Mr. Shreyas Yakkali | Medicine and Dentistry | Best Researcher Award

Resident at Jacobi Medical Center – – Bronx, NY, United States

Dr. Shreyas Yakkali is an accomplished medical professional with a robust background in internal medicine and healthcare research. Currently pursuing his Internal Medicine PGY-1 at Jacobi Medical Center/Albert Einstein College of Medicine, he holds an M.B.B.S. (MD Equivalent) from GS Medical College & KEM Hospital, Mumbai. Dr. Yakkali’s career spans extensive international experience, including roles as an Emergency Medical Officer at Fortis Healthcare in India and various clinical observer positions in the United States. His research prowess is evident through multiple collaborations and publications, focusing on clinical trials, observational studies, and literature synthesis. Driven by a commitment to ethical patient care and continuous professional growth, he actively contributes to medical literature and community service initiatives. Dr. Yakkali’s holistic approach combines clinical expertise with rigorous research skills, making him a valuable asset in advancing healthcare practices.

Professional Profiles

Education

Dr. Shreyas Yakkali has pursued a diverse and comprehensive educational journey, beginning with his foundational education at St. Pius X High School. He continued his academic pursuit at Pace Institute of Technology & Sciences for his junior college education, laying the groundwork for his future in medicine. Dr. Yakkali achieved his M.B.B.S. (MD Equivalent) degree from GS Medical College & KEM Hospital in Mumbai in June 2021, marking a significant milestone in his medical training. Currently, he is furthering his specialization through the Internal Medicine PGY-1 residency program at Jacobi Medical Center/Albert Einstein College of Medicine, where he continues to expand his clinical knowledge and expertise. His educational path reflects a commitment to excellence in healthcare and a dedication to continuous learning and professional growth in the medical field.

Professional Experience

Dr. Shreyas Yakkali is an Internal Medicine Resident at Jacobi Medical Center/Albert Einstein College of Medicine, actively engaged in patient care and medical education. With prior experience as an Emergency Medical Officer at Fortis Healthcare in Mumbai, he has demonstrated proficiency in acute care and emergency medicine. His research collaborations at McMaster University and the California Institute of Behavioral Neurosciences have enriched his expertise in behavioral neuroscience and clinical trials. Driven by a passion for advancing medical knowledge, Dr. Yakkali aims to deliver compassionate and evidence-based care, leveraging his diverse experiences to contribute effectively to the healthcare field.

Research Interest

Dr. Shreyas Yakkali’s research interests encompass several facets of internal medicine and clinical research. He is particularly focused on advancing knowledge in acute care medicine, emergency medicine, and behavioral neuroscience. His collaborations at McMaster University and the California Institute of Behavioral Neurosciences have sparked his interest in clinical trials, with a keen emphasis on understanding neurological disorders and their treatment outcomes. Dr. Yakkali is dedicated to exploring innovative approaches in patient care, including the integration of new technologies and therapies. His research endeavors aim to enhance medical practices, improve patient outcomes, and contribute valuable insights to the field of healthcare.

Award and Honors

Dr. Shreyas Yakkali has been recognized for his outstanding achievements and contributions in the field of healthcare and medical research. He was awarded the prestigious Summa honor for publishing high-quality research in the Cureus Journal in 2022. Additionally, he holds certifications in Advanced Cardiovascular Life Support (ACLS) and Basic Life Support (BLS) for Healthcare Providers from the American Heart Association, obtained in 2023. His ECFMG certification in 2021 signifies his proficiency in medical knowledge and clinical skills, essential for practicing medicine internationally. These honors underscore Dr. Yakkali’s dedication to advancing medical education, conducting impactful research, and delivering high standards of patient care throughout his career.

Research Skills

Dr. Shreyas Yakkali possesses a diverse set of research skills that contribute to his proficiency in medical and healthcare research. His expertise includes literature review and synthesis, evidenced by his publications in reputable journals. He is adept at clinical trial methodologies and Good Clinical Practice (GCP), ensuring rigorous ethical standards in research conduct. Dr. Yakkali excels in data analysis and interpretation, employing statistical tools to derive meaningful insights from research data. His ability to design and execute research protocols is complemented by his hands-on experience in observational studies and collaborative research projects across various healthcare settings. Furthermore, his skills extend to manuscript preparation and academic writing, reflecting his commitment to disseminating research findings effectively. Dr. Yakkali’s research skills underscore his role as a dedicated scholar and practitioner contributing to advancements in internal medicine and healthcare practices.

Publications

  1. Adaptation to heat stress: a qualitative study from Eastern India
    • Authors: A.K. Khetan, S. Yakkali, H.H. Dholakia, V. Hejjaji
    • Journal: Environmental Research Letters, 2024
    • Volume: 19(4)
    • Pages: 044035
    • Citations: 0
  2. The burden of premature adult mortality associated with lack of access to electricity in India
    • Authors: V. Hejjaji, D. Barbhaya, A. Rahimian, S. Yakkali, A.K. Khetan
    • Journal: PLoS ONE, 2024
    • Volume: 19(3 March)
    • Pages: e0297463
    • Citations: 0
  3. Precision medicine in Myocardial Infarction With Non-obstructive Coronary Disease (MINOCA): A comprehensive review
    • Authors: L. Fatima, A. Goyal, S. Yakkali, A.H. Sohail, J. Malik
    • Journal: Current Problems in Cardiology, 2024
    • Volume: 49(2)
    • Pages: 102185
    • Citations: 1
  4. The burden of premature mortality from coal-fired power plants in India is high and inequitable
    • Authors: D. Barbhaya, V. Hejjaji, A. Vijayaprakash, A.K. Khetan, A. Muralidharan, S. Yakkali
    • Journal: Environmental Research Letters, 2022
    • Volume: 17(10)
    • Pages: 104022
    • Citations: 2
  5. Reasons for Non-Referral for Autologous Stem Cell Transplantation in Central Nervous System Lymphoma (CNSL) Patients in a Minority-Rich, Multiracial, and Underprivileged Population at Montefiore Medical Center, Albert Einstein College of Medicine
    • Authors: H. Narvel, S. Yakkali, A.-H. Bazarbachi, I. Braunschweig, R.A. Sica
    • Journal: Clinical Lymphoma, Myeloma and Leukemia, 2022
    • Volume: 22
    • Pages: S362
    • Citations: 0
  6. Do Certain Biomarkers Predict Adverse Outcomes in Coronavirus Disease 2019?
    • Authors: H. Narvel, A. Sayed, N. Narvel, S. Yakkali, T. Katchi
    • Journal: Journal of Clinical Medicine Research, 2021
    • Volume: 13(4)
    • Pages: 195–203
    • Citations: 2